Skip to main content

Table 7 Complications and outcomes

From: Clinical and epidemiologic characterization of patients with systemic lupus erythematosus admitted to an intensive care unit in Colombia

Complications

n/N (%)

Infections

29/45 (64,4)

 • Nosocomial

20/29 (69,0)

  o Pneumonia

12/20 (60,0)

  o Urinary tract infection

7/20 (35,0)

  o Bacteriemia

7/20 (35,0)

  o Soft tissue

2/20 (10,0)

  o Intrabdominal

1/20 (5,0)

 • Acquired in the community

7/29 (24,1)

  o Urinary tract infection

3/7 (42,9)

  o Pneumonia

2/7 (28,6)

  o Bacteriemia

2/7 (28,6)

  o Soft tissue

1/7 (14,3)

  o Intrabdominal

1/7 (14,3)

 • Nosocomial and acquiered in community

2/29 (6,9)

Acute kidney injury

24/45 (53,3)

Re-admissions to ICU

7/45 (21,2)

Death

4/33 (12,1)

  1. Boldface is the values with stadistic signficance p < 0.05